Sialadenosis in Bulimia: A New Treatment
- 1 July 1993
- journal article
- case report
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 119 (7) , 787-788
- https://doi.org/10.1001/archotol.1993.01880190083017
Abstract
• Objective. —To see whether a cholinomimetic medication would help resolve the parotid gland enlargement associated with self-induced vomiting in bulimic patients. Setting/Design. —The medication was administered on an inpatient eating disorder unit to bulimic patients with refractory sialadenosis. Intervention. —Pilocarpine hydrochloride drops were administered orally at a dosage of 1.25 to 5.0 mg/d until the parotid gland enlargement was significantly reduced. Results. —There was a marked diminution in the size of the parotid gland enlargement. Conclusion. —Pilocarpine has proved to be beneficial in the treatment of sialadenosis in bulimic patients.(Arch Otolaryngol Head Neck Surg. 1993;119:787-788)Keywords
This publication has 4 references indexed in Scilit:
- Painful buccal mass in a patient with bulimia nervosaInternational Journal of Eating Disorders, 1991
- Parotid Salivary Secretory Pattern in Bulimia NervosaActa Oto-Laryngologica, 1991
- An investigation of the oral pathologies occurring in bulimia nervosaInternational Journal of Eating Disorders, 1990
- Benign Parotid Enlargement in BulimiaAnnals of Internal Medicine, 1980